SHEA has released a new consensus statement regarding pediatric-specific recommendations for Candida auris.

C. auris is a "multidrug-resistant fungal pathogen associated with healthcare-associated infections and outbreaks worldwide." SHEA's new consensus statement "addresses high-priority gaps for pediatric and child-serving settings, including neonatal intensive care units, pediatric hospitals and units, long-term care and rehabilitation facilities for children, schools, childcare settings, and family residential facilities."

The recommendations "address pediatric realities that differ from adult care, including caregiver rooming-in, breastfeeding and skin-to-skin practices, shared play and therapy spaces, specialized pediatric equipment, toys, breast pumps, and communication needs across healthcare and non-healthcare settings."

Some of the key recommendations include "providing plain-language education for caregivers and visitors, coordinating with local infection prevention and public health partners, using targeted screening based on defined exposures, maintaining rigorous environmental cleaning and disinfection with products effective against C. auris, and supporting thoughtful disclosure practices to avoid stigma or unnecessary exclusion of children in non-healthcare congregate settings."